Cetirizine 5 mg/5 ml (Syrup)
60 ml bottle: ৳ 16.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Cetirizine hydrochloride |
| Company | Apc pharma ltd |
| Also available as |
Indications
- Relief of symptoms associated with seasonal & perennial allergic rhinitis
- Treatment of uncomplicated skin manifestations of chronic idiopathic urticaria
- Treatment of allergen-induced asthma
Pharmacology
- Potent H1 receptor antagonist
- Inhibits histamine-mediated early phase of allergic reaction
- Reduces migration of inflammatory cells and release of mediators associated with late phase of allergic reaction
- Almost no drowsiness effect
- Does not cause behavioral changes
- Peak plasma concentration of 257 mcg/L within one hour of administration
Dosage & Administration
- Adult dosage: 1 tablet or 2 teaspoonfuls daily
- Children 6 years and older dosage: 1 tablet or 2 teaspoonfuls daily
- Children 2-6 years dosage: 1 teaspoonful once daily or 1/2 teaspoonful twice daily
- Children 6 months to 2 years dosage: 1/2 teaspoonful once daily
- Injectable dosage for adults and adolescents: 10 mg administered by intravenous injection
- Injectable dosage for children 6 to 11 years: 5 mg or 10 mg depending on symptom severity administered by intravenous injection
- Injectable dosage for children 6 months to 5 years: 2.5 mg administered by intravenous injection
Interaction
- No clinically significant drug interactions with Theophylline
- No clinically significant drug interactions with Azithromycin
- No clinically significant drug interactions with Pseudoephedrine
- No clinically significant drug interactions with Ketoconazole
- No clinically significant drug interactions with Erythromycin
Contraindications
- Hypersensitivity to Cetirizine or hydroxyzine
Side Effects
- Somnolence
Pregnancy & Lactation
- US FDA Pregnancy Category: B
- No adequate and well-controlled studies in pregnant women
- Cetirizine Hydrochloride excreted in human milk
- Caution advised when administered to nursing women
Precautions & Warnings
- Caution advised when driving a car or operating heavy machinery
Use in Special Populations
- Total body clearance reduced with mild to moderate hepatic and renal impairment
- Safety demonstrated in pediatric patients aged 6 months to 5 years
- Clearance reduced in elderly patients in proportion to decrease in creatinine clearance
Therapeutic Class
- Sedating Antihistamine
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children